The global NGS-Based Monitoring and Diagnostic Test market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Agilent Technologies, Inc.
GenePath Dx
Beijing Genomics Institute (BGI)
Ancestry.com LLC
F. Hoffmann-La Roche Ltd
ArcherDX, Inc.
Laboratory Corporation of America Holdings
CENTOGENE AG
Cancer Genetics, Inc.
Illumina, Inc.
Thermo Fisher Scientific Inc.
Myriad Genetics, Inc.
HTG Molecular Diagnostics, Inc.
Siemens Healthineers, Inc.
QIAGEN N.V.
Vela Diagnostics Pte. Ltd.
Quest Diagnostics Incorporated
By Types:
Commercial Assays/Tests
Laboratory Developed Tests
Direct to Consumer Test
Pre-Commercial Tests
By Applications:
Out-Patient Clinics/General Practitioners
Diagnostic Centers
Hospitals
Others
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global NGS-Based Monitoring and Diagnostic Test Market Size Analysis from 2023 to 2028
1.5.1 Global NGS-Based Monitoring and Diagnostic Test Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global NGS-Based Monitoring and Diagnostic Test Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global NGS-Based Monitoring and Diagnostic Test Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: NGS-Based Monitoring and Diagnostic Test Industry Impact
Chapter 2 Global NGS-Based Monitoring and Diagnostic Test Competition by Types, Applications, and Top Regions and Countries
2.1 Global NGS-Based Monitoring and Diagnostic Test (Volume and Value) by Type
2.1.1 Global NGS-Based Monitoring and Diagnostic Test Consumption and Market Share by Type (2017-2022)
2.1.2 Global NGS-Based Monitoring and Diagnostic Test Revenue and Market Share by Type (2017-2022)
2.2 Global NGS-Based Monitoring and Diagnostic Test (Volume and Value) by Application
2.2.1 Global NGS-Based Monitoring and Diagnostic Test Consumption and Market Share by Application (2017-2022)
2.2.2 Global NGS-Based Monitoring and Diagnostic Test Revenue and Market Share by Application (2017-2022)
2.3 Global NGS-Based Monitoring and Diagnostic Test (Volume and Value) by Regions
2.3.1 Global NGS-Based Monitoring and Diagnostic Test Consumption and Market Share by Regions (2017-2022)
2.3.2 Global NGS-Based Monitoring and Diagnostic Test Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global NGS-Based Monitoring and Diagnostic Test Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global NGS-Based Monitoring and Diagnostic Test Consumption by Regions (2017-2022)
4.2 North America NGS-Based Monitoring and Diagnostic Test Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia NGS-Based Monitoring and Diagnostic Test Sales, Consumption, Export, Import (2017-2022)
4.4 Europe NGS-Based Monitoring and Diagnostic Test Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia NGS-Based Monitoring and Diagnostic Test Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia NGS-Based Monitoring and Diagnostic Test Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East NGS-Based Monitoring and Diagnostic Test Sales, Consumption, Export, Import (2017-2022)
4.8 Africa NGS-Based Monitoring and Diagnostic Test Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania NGS-Based Monitoring and Diagnostic Test Sales, Consumption, Export, Import (2017-2022)
4.10 South America NGS-Based Monitoring and Diagnostic Test Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America NGS-Based Monitoring and Diagnostic Test Market Analysis
5.1 North America NGS-Based Monitoring and Diagnostic Test Consumption and Value Analysis
5.1.1 North America NGS-Based Monitoring and Diagnostic Test Market Under COVID-19
5.2 North America NGS-Based Monitoring and Diagnostic Test Consumption Volume by Types
5.3 North America NGS-Based Monitoring and Diagnostic Test Consumption Structure by Application
5.4 North America NGS-Based Monitoring and Diagnostic Test Consumption by Top Countries
5.4.1 United States NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
5.4.2 Canada NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
5.4.3 Mexico NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
Chapter 6 East Asia NGS-Based Monitoring and Diagnostic Test Market Analysis
6.1 East Asia NGS-Based Monitoring and Diagnostic Test Consumption and Value Analysis
6.1.1 East Asia NGS-Based Monitoring and Diagnostic Test Market Under COVID-19
6.2 East Asia NGS-Based Monitoring and Diagnostic Test Consumption Volume by Types
6.3 East Asia NGS-Based Monitoring and Diagnostic Test Consumption Structure by Application
6.4 East Asia NGS-Based Monitoring and Diagnostic Test Consumption by Top Countries
6.4.1 China NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
6.4.2 Japan NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
6.4.3 South Korea NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
Chapter 7 Europe NGS-Based Monitoring and Diagnostic Test Market Analysis
7.1 Europe NGS-Based Monitoring and Diagnostic Test Consumption and Value Analysis
7.1.1 Europe NGS-Based Monitoring and Diagnostic Test Market Under COVID-19
7.2 Europe NGS-Based Monitoring and Diagnostic Test Consumption Volume by Types
7.3 Europe NGS-Based Monitoring and Diagnostic Test Consumption Structure by Application
7.4 Europe NGS-Based Monitoring and Diagnostic Test Consumption by Top Countries
7.4.1 Germany NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
7.4.2 UK NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
7.4.3 France NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
7.4.4 Italy NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
7.4.5 Russia NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
7.4.6 Spain NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
7.4.7 Netherlands NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
7.4.8 Switzerland NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
7.4.9 Poland NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
Chapter 8 South Asia NGS-Based Monitoring and Diagnostic Test Market Analysis
8.1 South Asia NGS-Based Monitoring and Diagnostic Test Consumption and Value Analysis
8.1.1 South Asia NGS-Based Monitoring and Diagnostic Test Market Under COVID-19
8.2 South Asia NGS-Based Monitoring and Diagnostic Test Consumption Volume by Types
8.3 South Asia NGS-Based Monitoring and Diagnostic Test Consumption Structure by Application
8.4 South Asia NGS-Based Monitoring and Diagnostic Test Consumption by Top Countries
8.4.1 India NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
8.4.2 Pakistan NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
8.4.3 Bangladesh NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia NGS-Based Monitoring and Diagnostic Test Market Analysis
9.1 Southeast Asia NGS-Based Monitoring and Diagnostic Test Consumption and Value Analysis
9.1.1 Southeast Asia NGS-Based Monitoring and Diagnostic Test Market Under COVID-19
9.2 Southeast Asia NGS-Based Monitoring and Diagnostic Test Consumption Volume by Types
9.3 Southeast Asia NGS-Based Monitoring and Diagnostic Test Consumption Structure by Application
9.4 Southeast Asia NGS-Based Monitoring and Diagnostic Test Consumption by Top Countries
9.4.1 Indonesia NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
9.4.2 Thailand NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
9.4.3 Singapore NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
9.4.4 Malaysia NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
9.4.5 Philippines NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
9.4.6 Vietnam NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
9.4.7 Myanmar NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
Chapter 10 Middle East NGS-Based Monitoring and Diagnostic Test Market Analysis
10.1 Middle East NGS-Based Monitoring and Diagnostic Test Consumption and Value Analysis
10.1.1 Middle East NGS-Based Monitoring and Diagnostic Test Market Under COVID-19
10.2 Middle East NGS-Based Monitoring and Diagnostic Test Consumption Volume by Types
10.3 Middle East NGS-Based Monitoring and Diagnostic Test Consumption Structure by Application
10.4 Middle East NGS-Based Monitoring and Diagnostic Test Consumption by Top Countries
10.4.1 Turkey NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
10.4.3 Iran NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
10.4.5 Israel NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
10.4.6 Iraq NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
10.4.7 Qatar NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
10.4.8 Kuwait NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
10.4.9 Oman NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
Chapter 11 Africa NGS-Based Monitoring and Diagnostic Test Market Analysis
11.1 Africa NGS-Based Monitoring and Diagnostic Test Consumption and Value Analysis
11.1.1 Africa NGS-Based Monitoring and Diagnostic Test Market Under COVID-19
11.2 Africa NGS-Based Monitoring and Diagnostic Test Consumption Volume by Types
11.3 Africa NGS-Based Monitoring and Diagnostic Test Consumption Structure by Application
11.4 Africa NGS-Based Monitoring and Diagnostic Test Consumption by Top Countries
11.4.1 Nigeria NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
11.4.2 South Africa NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
11.4.3 Egypt NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
11.4.4 Algeria NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
11.4.5 Morocco NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
Chapter 12 Oceania NGS-Based Monitoring and Diagnostic Test Market Analysis
12.1 Oceania NGS-Based Monitoring and Diagnostic Test Consumption and Value Analysis
12.2 Oceania NGS-Based Monitoring and Diagnostic Test Consumption Volume by Types
12.3 Oceania NGS-Based Monitoring and Diagnostic Test Consumption Structure by Application
12.4 Oceania NGS-Based Monitoring and Diagnostic Test Consumption by Top Countries
12.4.1 Australia NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
12.4.2 New Zealand NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
Chapter 13 South America NGS-Based Monitoring and Diagnostic Test Market Analysis
13.1 South America NGS-Based Monitoring and Diagnostic Test Consumption and Value Analysis
13.1.1 South America NGS-Based Monitoring and Diagnostic Test Market Under COVID-19
13.2 South America NGS-Based Monitoring and Diagnostic Test Consumption Volume by Types
13.3 South America NGS-Based Monitoring and Diagnostic Test Consumption Structure by Application
13.4 South America NGS-Based Monitoring and Diagnostic Test Consumption Volume by Major Countries
13.4.1 Brazil NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
13.4.2 Argentina NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
13.4.3 Columbia NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
13.4.4 Chile NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
13.4.5 Venezuela NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
13.4.6 Peru NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
13.4.8 Ecuador NGS-Based Monitoring and Diagnostic Test Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in NGS-Based Monitoring and Diagnostic Test Business
14.1 Agilent Technologies, Inc.
14.1.1 Agilent Technologies, Inc. Company Profile
14.1.2 Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Product Specification
14.1.3 Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 GenePath Dx
14.2.1 GenePath Dx Company Profile
14.2.2 GenePath Dx NGS-Based Monitoring and Diagnostic Test Product Specification
14.2.3 GenePath Dx NGS-Based Monitoring and Diagnostic Test Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Beijing Genomics Institute (BGI)
14.3.1 Beijing Genomics Institute (BGI) Company Profile
14.3.2 Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Product Specification
14.3.3 Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Ancestry.com LLC
14.4.1 Ancestry.com LLC Company Profile
14.4.2 Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Product Specification
14.4.3 Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 F. Hoffmann-La Roche Ltd
14.5.1 F. Hoffmann-La Roche Ltd Company Profile
14.5.2 F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Product Specification
14.5.3 F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 ArcherDX, Inc.
14.6.1 ArcherDX, Inc. Company Profile
14.6.2 ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Product Specification
14.6.3 ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Laboratory Corporation of America Holdings
14.7.1 Laboratory Corporation of America Holdings Company Profile
14.7.2 Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Product Specification
14.7.3 Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 CENTOGENE AG
14.8.1 CENTOGENE AG Company Profile
14.8.2 CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Product Specification
14.8.3 CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Cancer Genetics, Inc.
14.9.1 Cancer Genetics, Inc. Company Profile
14.9.2 Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product Specification
14.9.3 Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Illumina, Inc.
14.10.1 Illumina, Inc. Company Profile
14.10.2 Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Product Specification
14.10.3 Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Thermo Fisher Scientific Inc.
14.11.1 Thermo Fisher Scientific Inc. Company Profile
14.11.2 Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Product Specification
14.11.3 Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 Myriad Genetics, Inc.
14.12.1 Myriad Genetics, Inc. Company Profile
14.12.2 Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product Specification
14.12.3 Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 HTG Molecular Diagnostics, Inc.
14.13.1 HTG Molecular Diagnostics, Inc. Company Profile
14.13.2 HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Product Specification
14.13.3 HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.14 Siemens Healthineers, Inc.
14.14.1 Siemens Healthineers, Inc. Company Profile
14.14.2 Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Product Specification
14.14.3 Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.15 QIAGEN N.V.
14.15.1 QIAGEN N.V. Company Profile
14.15.2 QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Product Specification
14.15.3 QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.16 Vela Diagnostics Pte. Ltd.
14.16.1 Vela Diagnostics Pte. Ltd. Company Profile
14.16.2 Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Product Specification
14.16.3 Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.17 Quest Diagnostics Incorporated
14.17.1 Quest Diagnostics Incorporated Company Profile
14.17.2 Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Product Specification
14.17.3 Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global NGS-Based Monitoring and Diagnostic Test Market Forecast (2023-2028)
15.1 Global NGS-Based Monitoring and Diagnostic Test Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global NGS-Based Monitoring and Diagnostic Test Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global NGS-Based Monitoring and Diagnostic Test Value and Growth Rate Forecast (2023-2028)
15.2 Global NGS-Based Monitoring and Diagnostic Test Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global NGS-Based Monitoring and Diagnostic Test Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global NGS-Based Monitoring and Diagnostic Test Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America NGS-Based Monitoring and Diagnostic Test Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia NGS-Based Monitoring and Diagnostic Test Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe NGS-Based Monitoring and Diagnostic Test Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia NGS-Based Monitoring and Diagnostic Test Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia NGS-Based Monitoring and Diagnostic Test Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East NGS-Based Monitoring and Diagnostic Test Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa NGS-Based Monitoring and Diagnostic Test Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania NGS-Based Monitoring and Diagnostic Test Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America NGS-Based Monitoring and Diagnostic Test Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global NGS-Based Monitoring and Diagnostic Test Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global NGS-Based Monitoring and Diagnostic Test Consumption Forecast by Type (2023-2028)
15.3.2 Global NGS-Based Monitoring and Diagnostic Test Revenue Forecast by Type (2023-2028)
15.3.3 Global NGS-Based Monitoring and Diagnostic Test Price Forecast by Type (2023-2028)
15.4 Global NGS-Based Monitoring and Diagnostic Test Consumption Volume Forecast by Application (2023-2028)
15.5 NGS-Based Monitoring and Diagnostic Test Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
| Price : US$ 3500 |
Date : Apr 2024 |
| Category : Electronics |
Pages : 129 |
| Price : US$ 3500 |
Date : Apr 2024 |
| Category : Services |
Pages : 135 |
Request Sample 
Request Discount 
Inquire Before Buy
